CA1176158A - Pharmaceutical formulations comprising human insulin and human c-peptide - Google Patents

Pharmaceutical formulations comprising human insulin and human c-peptide

Info

Publication number
CA1176158A
CA1176158A CA000409900A CA409900A CA1176158A CA 1176158 A CA1176158 A CA 1176158A CA 000409900 A CA000409900 A CA 000409900A CA 409900 A CA409900 A CA 409900A CA 1176158 A CA1176158 A CA 1176158A
Authority
CA
Canada
Prior art keywords
human
insulin
peptide
composition
human insulin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000409900A
Other languages
English (en)
French (fr)
Inventor
Ronald E. Chance
Bruce H. Frank
John A. Galloway
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of CA1176158A publication Critical patent/CA1176158A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CA000409900A 1981-08-27 1982-08-23 Pharmaceutical formulations comprising human insulin and human c-peptide Expired CA1176158A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29671581A 1981-08-27 1981-08-27
US296,715 1981-08-27

Publications (1)

Publication Number Publication Date
CA1176158A true CA1176158A (en) 1984-10-16

Family

ID=23143238

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000409900A Expired CA1176158A (en) 1981-08-27 1982-08-23 Pharmaceutical formulations comprising human insulin and human c-peptide

Country Status (20)

Country Link
JP (1) JPS5846024A (de)
AU (1) AU551879B2 (de)
BE (1) BE894185A (de)
CA (1) CA1176158A (de)
CH (1) CH650679A5 (de)
DE (1) DE3232034A1 (de)
DZ (1) DZ452A1 (de)
FR (1) FR2513126B1 (de)
GB (1) GB2104382B (de)
IE (1) IE54119B1 (de)
IL (1) IL66611A0 (de)
IT (1) IT1153182B (de)
LU (1) LU84359A1 (de)
MW (1) MW3882A1 (de)
NL (1) NL192192C (de)
NZ (1) NZ201682A (de)
PH (1) PH19361A (de)
SE (1) SE460334B (de)
ZA (1) ZA826159B (de)
ZW (1) ZW17482A1 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6610649B2 (en) 1996-09-27 2003-08-26 Creative Peptides Sweden Ab Insulin C-peptides

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3326473A1 (de) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
JPH01501389A (ja) * 1986-10-20 1989-05-18 ノボ　インダストリ　アクティーゼルスカブ ポリペプチド製剤
CA1296253C (en) * 1986-10-20 1992-02-25 Praveen Tyle Stabilized growth hormone compositions
EP0280534B1 (de) * 1987-02-25 1993-04-21 Novo Nordisk A/S Insulinderivate
US5212154A (en) * 1987-08-14 1993-05-18 Akzo N.V. Preparation for treating complications in diabetes
ATE63821T1 (de) * 1987-08-14 1991-06-15 Akzo Nv Praeparat zur verhuetung oder bekaempfung von komplikationen bei diabetes.
GB0323979D0 (en) 2003-10-13 2003-11-19 Creative Peptides Sweden Ab Therapeutic applications for c-peptide
CN101060856B (zh) * 2004-11-22 2011-01-19 诺和诺德公司 可溶、稳定的含胰岛素制剂
GB0511269D0 (en) 2005-06-02 2005-07-13 Creative Peptides Sweden Ab Sustained release preparation of pro-insulin C-peptide
GB0601950D0 (en) * 2006-01-31 2006-03-15 Creative Peptides Sweden Ab Compositions and methods of treating diabetes
EP2341942A1 (de) 2008-09-19 2011-07-13 Nektar Therapeutics Polymerkonjugate aus therapeutischen peptiden
CN103119055A (zh) 2010-05-17 2013-05-22 塞比克斯公司 聚乙二醇化c肽
CA2855770A1 (en) 2011-11-17 2013-05-23 Cebix Ab Pegylated c-peptide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2789080A (en) * 1952-08-14 1957-04-16 Christensen Henry Marinus Insulin-albumin compositions
CH330318A (de) * 1953-09-08 1958-05-31 British Drug Houses Ltd Verfahren zur Herstellung eines Insulinpräparates mit verlängerter Wirkungszeit

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6610649B2 (en) 1996-09-27 2003-08-26 Creative Peptides Sweden Ab Insulin C-peptides

Also Published As

Publication number Publication date
IT1153182B (it) 1987-01-14
ZW17482A1 (en) 1982-11-17
JPS5846024A (ja) 1983-03-17
SE8204873D0 (sv) 1982-08-25
AU551879B2 (en) 1986-05-15
ZA826159B (en) 1984-04-25
DZ452A1 (fr) 2004-09-13
LU84359A1 (fr) 1983-02-28
GB2104382A (en) 1983-03-09
PH19361A (en) 1986-04-02
FR2513126B1 (fr) 1986-04-18
IT8223017A0 (it) 1982-08-27
DE3232034A1 (de) 1983-03-10
SE8204873L (sv) 1983-02-28
IL66611A0 (en) 1982-12-31
CH650679A5 (de) 1985-08-15
IE822064L (en) 1983-02-27
GB2104382B (en) 1984-12-19
SE460334B (sv) 1989-10-02
DE3232034C2 (de) 1991-04-11
MW3882A1 (en) 1984-07-11
NL192192B (nl) 1996-11-01
IE54119B1 (en) 1989-06-21
BE894185A (fr) 1983-02-24
NL192192C (nl) 1997-03-04
NZ201682A (en) 1985-08-16
AU8759482A (en) 1983-03-03
NL8203315A (nl) 1983-03-16
FR2513126A1 (fr) 1983-03-25

Similar Documents

Publication Publication Date Title
CA1176158A (en) Pharmaceutical formulations comprising human insulin and human c-peptide
CA1176161A (en) Pharmaceutical formulations comprising human insulin and human proinsulin
KR100546225B1 (ko) 신속한 작용개시를 나타내는 인슐린 유도체
US4652548A (en) Pharmaceutical formulations comprising human insulin, human C-peptide, and human proinsulin
RU2176646C2 (ru) Инсулин и его производные с повышенной способностью связывать цинк
JPH0196137A (ja) 真性糖尿病の治療
ZA200600846B (en) Novel insulin derivatives
US4654324A (en) Human proinsulin pharmaceutical formulations
JP4402296B2 (ja) 亜鉛結合性が増大された新規なインスリン同族体
CA1176160A (en) Human proinsulin pharmaceutical formulations
CA1176159A (en) Pharmaceutical formulations comprising human insulin, human c-peptide, and human proinsulin
WO1998041222A1 (en) Obesity protein formulations
JPH08188538A (ja) ニューロレプト麻酔時の血圧調節剤

Legal Events

Date Code Title Description
MKEC Expiry (correction)
MKEX Expiry